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ABSTRACT 
Water soluble trialkylphosphines such as tris(carboxyethyl)phosphine (TCEP) and 
trishydroxypropyl phosphine (THPP) are effective agents for reducing disulfide bonds in 
proteins and are increasingly becoming the reagents of choice for bioconjugation strategies 
which modify cysteine (thiol containing) amino acids. These reducing agents are often 
considered as being chemically compatible with Michael acceptors such as maleimides and, 
as such, are often not removed prior to performing protein conjugation reactions. Here we 
demonstrate the rapid and irreversible reaction of both TCEP and THPP with derivatives of 
the commonly employed thiol alkylating groups, maleimide and vinyl sulphone. Mechanistic 
investigations revealed distinct differences between the reactions of TCEP and THPP with 
maleimide, leading to the production of either non-productive ylenes or succidimidyl 
derivatives, respectively. Importantly, we also demonstrate the incorporation of non-
productive ylenes formed between maleimide and TCEP into the Pneumococcal capsular 
polysaccharide Pn6b following strategies employed towards the production of conjugate 
vaccines. 
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INTRODUCTION  
Bioconjugation reactions involving the modification of cysteine sulfhydryl groups have 
been used successfully to produce a wide variety of medicinally useful derivatives including 
PEGylated protein therapeutics, conjugate vaccines and, more recently, antibody drug 
conjugates (ADC’s).1-7 At pH’s commonly employed for these conjugations (pH 7-8), it is 
predominantly the deprotonated sulfhydryl group, the thiolate anion, that is responsible for 
the highly nucleophilic characteristics of cysteine.8 However, there is a strong tendency for 
cysteinyl thiols to oxidise to disulfides under aqueous conditions, or in some circumstances, 
to higher oxidation states resulting in sulfenic or sulfinic acids.9 Unfortunately, these oxidised 
states of cysteine render the sulfur atom inert towards commonly used Michael acceptors 
such as maleimides and vinylsulfones.10 A prerequisite therefore for many bioconjugation 
strategies based on conjugate addition by a thiol, first involves reduction of the cysteinyl 
sulphur to the sulfhydryl group prior to performing the conjugation step. In particular, the 
reduction of antibody interchain disulfide bridges is essential to enable attachment of 
cytotoxic payloads in the synthesis of ADC’s such as brentuximab vedotin (Adcetris™).11 
Water soluble alkylphosphines have established themselves as popular reducing 
reagents for effecting the liberation of peptidyl thiols, as they provide numerous advantages 
over the traditional thiol based reagents such as dithiothreitol (DTT), β-mercaptoethanol 
(BME) and β-mercaptoethylamine (2-MEA).12-14 The phosphorus atom of commercial water-
soluble alkylphosphines have pKa’s of 7-8 which is a common pH range for performing 
bioconjugations and as such, the trialkylphosphines are more effective nucleophiles than 
thiol-based reducing agents to effect reduction within this pH range.15 Furthermore, disulfide 
reduction utilising alkylphosphines are irreversible and driven by phosphorus-oxygen bond 
formation, unlike the reversible mechanism of disulfide reduction observed with thiol-
containing reducing agents.15 The two most commonly used water soluble alkylphosphines 
are tris-(2-carboxyethyl)phosphine (TCEP) 1 and tris-(3-hydroxypropyl)phosphine (THPP) 2 
(Figure 1), with both reagents being effectively odourless and relatively stable towards 
oxygen dependant oxidation over a useful pH range for bioconjugation reactions.15-17 
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Figure 1. Structures of the trialkyl phosphine reducing agents TCEP (1) and THPP (2). 
 
In addition to the favourable physico-chemical properties of TCEP and THPP, these 
reagents are also considered generally to provide methodological advantages over thiol based 
reducing agents, with reports in the literature that TCEP is unreactive towards maleimide and 
numerous examples of maleimide-based conjugations being performed in the presence of 
TCEP.18-24 Contrary to this however, a number of groups have reported decreased yields of 
conjugation when using maleimide in the presence of TCEP, suggesting possible reaction 
between the two reagents.25-28 Recently, Sánchez et al. have reported the observation of a 
phosphonium-ion adduct between TCEP and maleimide on the basis of mass spectrometry, 
though this adduct was not fully characterised.28  
In this study we demonstrate that the water soluble phosphine reducing agents TCEP 
and THPP both react rapidly with maleimides and phenyl vinyl sulfone under conditions 
typically employed for bioconjugation reactions. We have performed full chemical 
characterisation on the reduction products formed, as well as investigated the mechanism of 
these reactions. In all cases, phosphines were found to reduce maleimides and vinylsulfones 
to species no longer capable of undergoing Michael addition with cysteinyl thiols, resulting in 
reduced yields of conjugation. Finally, we have evaluated the potential impact that the 
irreversible reaction between maleimide and phosphine reducing agents may have on 
common conjugation methods and demonstrate the potential for phosphine adducts to be 
incorporated within products of conjugation reactions which utilise components 
functionalised with multiple maleimides. 
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RESULTS AND DISCUSSION 
Reaction of trialkylphosphines with maleimides. Initial investigations into a reaction 
between TCEP and maleimide were performed under conditions commonly employed in 
protein conjugations utilising N-ethyl maleimide (3) as a model substrate, as it was considered 
that this simple structure may facilitate the characterisation of any adducts formed. 
Treatment of TCEP (1) with a solution of N-ethyl maleimide (3) (pH 7, phosphate buffer) at 
room temperature resulted in the rapid formation of the TCEP-maleimide adduct 4, which 
was isolated in 73% yield (Scheme 1). This adduct can be represented in either the ylene or 
ylide resonance forms. 1H- and 13C- NMR spectroscopy allowed us to judge which 
representation is closer to the structure of 4. However, IR analysis showed a significant 
absorption at 1229 cm-1 which is indicative of a P=C bond (usual range 1180-1230 cm-1), 
suggesting that the ylene is a better description of the structure.  
 
 
Scheme 1. Reaction of N-ethyl maleimide (3) with TCEP (1) and THPP (2). (a) 1 (0.9 equiv.), THF/ 0.1M sodium 
phosphate (10 % v/v), pH 7, RT, 1 h. (b) 2 (1.0 equiv.), THF/ 0.1M sodium phosphate (10 % v/v), pH 7, RT, 1 h. 
 
 To demonstrate that the observed reaction was not simply a consequence of the 
reactive nature of the model substrate (3), the N-lysine maleimide derivative (5) was also 
treated with TCEP (1) under reaction conditions used previously. Here the ylene (6) was 
isolated in 70% yield, with IR analysis again confirming the structure as closer to the ylene 
(Scheme 2). The results observed here are consistent with previous observations that TCEP 
indeed reacts with maleimide to generate a phosphorus-containing adduct; however, it is 
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proposed here that this adduct is closer in structure to the neutral ylene rather than the 
phosphonium ylide proposed previously.27-29  
 
 
Scheme 2. Reaction of lysine derivatized maleimide (5) with TCEP (1) and THPP (2). (a) 1 (0.9 equiv.), THF/ 
0.1M sodium phosphate (10 % v/v), pH 7, RT, 1 h. (b) 2 (0.9 equiv.), THF/ 0.1M sodium phosphate (10 % v/v), 
pH 7, RT, 1 h. 
 
 
Having characterised the products of reactions between TCEP (1) and the maleimide 
derivatives (3) and (5), it was then of interest to evaluate the generality of this reaction using 
other water soluble trialkyl phosphines. As such, the reactivity of the trihydroxyalkyl 
phosphine THPP (2) was investigated towards the same maleimide substrates. Interestingly, 
treatment of THPP with (3) under conditions used previously resulted in saturation of the 
maleimide group to give N-ethyl succinimide (7) in 61% yield (Scheme 1). Similarly, treatment 
of (5) with THPP resulted in formation of the succinimide (8) in 59% yield, rather than a 
phosphorus-based ylene as observed previously with TCEP. The reduction of maleimide to 
succinimide by a trialkylphosphine is not without precedent however, as Pal et. al. have 
reported previously that reduction of maleimides can be effected using triphenylphosphine 
in refluxing methanol.30 
In light of the unexpected difference in products observed between the reactions of 
maleimides with TCEP and THPP, it was of interest to investigate mechanisms through which 
both reactions were operating. Repeating the reaction of TCEP (1) with N-ethyl maleimide (3) 
in deuterated phosphate buffer resulted in the formation of the ylene (9), where 1H NMR 
identified the incorporation of a single deuterium atom at C-4. Likely, this reaction is 
proceeding through nucleophilic attack of the phosphorus atom at C-3 of maleimide, followed 
by double bond cleavage and deuteration at C-4, as shown in Scheme 3. Deprotonation of the 
intermediate phosphonium ion (at C-3) then generates (9).  
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Scheme 3. Proposed mechanism for reaction of N-ethyl maleimide with trialkyl phosphines TCEP 1 (0.9 equiv.) 
or THPP 2 (0.9 equiv.) in THF/ 0.1 M deuterated phosphate buffer (10% v/v, pH 7) at room temperature for 1 
hour. 
 
 
When the reaction of N-ethyl maleimide with THPP was repeated in deuterated 
phosphate buffer, 1H NMR analysis revealed that three deuterium atoms were incorporated 
into the succinimide product. This suggests that the initial reaction of THPP with maleimide 
follows a similar mechanism to that of TCEP through transient formation of the phosphine 
intermediate (10), which is subsequently hydrolysed to the tri-deuterated succinimide (11) as 
shown in Scheme 3. As such, the different products observed from the reaction of maleimides 
with either TCEP or THPP arises from the relative susceptibility of the respective phosphine 
adducts (9 and 10) towards hydrolysis, rather than the reactions proceeding through a 
different mechanism. Given that the pKa’s of the phosphorus atoms of TCEP and THPP are 
very similar (7.7 and 7.2 respectively),17 it is unlikely the observed difference in stability 
between (9) and (10) is solely a result of inductive differences between the carboxyl and 
hydroxyl sidechains. One possibility is that compound 10 is more ylide-like in character, 
making the phosphorus atom more susceptible to nucleophilic attack by water. 
 
Reaction of trialkylphosphines with phenyl vinyl sulfone. Vinyl sulfones are an 
alternative class of thiol alkylating reagents to maleimides which have been used in a variety 
of bioconjugation reactions.31,32 Like maleimides, vinyl sulfones are Michael acceptors and 
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react with a similar range of nucleophiles, so it was of interest to investigate the reactivity of 
a vinyl sulfone towards trialkyl phosphines. Treatment of phenyl vinyl sulfone (12) with TCEP 
in phosphate buffer (pH=7) under similar conditions to those employed previously on 
maleimides resulted in formation of a TCEP-sulfone adduct which was isolated in 84% yield 
following purification (Scheme 4). NMR spectra (1H and 13C) of the product confirms the 
presence of two protons on carbon-2 of the ethyl sulfone, indicating the phosphorus atom is 
attached through a single bond. The carbonyl region of the IR spectrum shows two distinct 
absorption bands at 1600-1721 cm-1 which is consistent with cyclic oxaphospholanes reported 
previously.33 On this basis, we propose the product likely exists as compound 13.  
When considering the reasons behind the different products from reaction of TCEP 
with maleimide or vinyl sulfone, it is likely that the acidity of the proton on the carbon atom 
undergoing nucleophilic attack by phosphorus plays a key role in determining the products 
formed. In the case of the compound 12, the protons on carbon-2 of the ethyl sulfone are not 
abstracted and so the initial phosphonium-ion formed is now stabilised through intereaction 
with a sidechain carboxylate. 
 
   
Scheme 4. Reaction of phenyl vinyl sulfone (12) with TCEP (1) and THPP (2). (a) 1 (0.9 equiv.), THF/ 0.1M 
sodium phosphate (20 % v/v), pH 7, RT, 1 h. (b) 2 (0.9 equiv.), THF/ 0.1M sodium phosphate (10 % v/v), pH 7, 
RT, 1 h. 
 
 In contrast to TCEP, the reaction of THPP with phenyl vinyl sulfone 12 under similar 
conditions resulted in rapid consumption of the vinyl group to produce a complex mixture of 
aromatic containing species that could not be purified or characterised. Here, it is likely that 
the phosphorus atom of THPP undergoes addition to the vinyl group of 12 in a similar manner 
to TCEP, however the phosphonium-ion species generated (14) is unable to be stabilised 
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through either loss of a proton to form an ylide, or from participation of a sidechain group to 
form a cyclic oxaphospholane. Instead, breakdown of 14 occurs through several unidentified 
pathways. 
 
 
Implications for the reaction between maleimide and trialkylphosphines on 
bioconjugations strategies. It has been demonstrated here that the trialkyl phosphines TCEP 
and THPP react rapidly with the Michael acceptor maleimide under commonly employed 
bioconjugation conditions. To understand the impact these reactions may have on 
conjugation strategies it is first necessary to consider the nature of the products formed. For 
the reduction of maleimide by THPP, it is clear that the succinimide products are incapable of 
undergoing subsequent addition to a cysteinyl thiol, so this reaction will result in consumption 
of alkylating reagent. For the case of the TCEP reaction with maleimide however, the impact 
on bioconjugation is not immediately obvious as the ylene product formed could itself 
undergo nucleophilic attack by thiols. As such, we sought to investigate the ability of the ylene 
4 to undergo reaction with thiols. Solutions of the ylene 4 were generated in situ by reaction 
of TCEP with N-ethyl maleimide and subsequently incubated overnight with a solution of the 
cysteine containing peptide glutathione in phosphate buffer. Furthermore, the incubations 
were performed over a range of pH’s (4, 7 and 8) to investigate any influence that protonation 
state of the side-chain carboxylate may have on ylene stability. The reactions were monitored 
by 31P NMR or HRMS for loss of the ylene and formation of any product of conjugation. Under 
all conditions, no change was observed in the ylene 4 after 24 hours, suggesting that this 
adduct is indeed a ‘dead-end’ product and inert towards reaction with cysteinyl thiols. It is 
worthy of mention, however, that Sánchez et al. report a phosphonium-ion adduct formed 
between TCEP and maleimide was converted to a succinimide product.28 Unfortunately the 
reaction conditions necessary to effect this conversion are not reported. 
 
The effect of performing protein PEGylations with maleimide in the presence of 
trialkylphosphines. As the reaction of TCEP with maleimide results in formation of a non-
productive ylene and hence, loss of active alkylating reagent, the impact on bioconjugation 
will be dictated by the relative rates of reactions between maleimide with either the cysteinyl 
thiol or the phosphine reducing agent. These observations are consistent with a previous 
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report by Tyagarajan et al. where the yield of conjugation of maleimide containing fluorescent 
dyes onto cysteine containing proteins was reduced when performing the reactions in the 
presence of TCEP.26 It was of interest to us to expand on these observations and investigate 
the impact of performing maleimide based protein PEGylation reactions in the presence of 
TCEP.  
Here, yeast enolase (47 kDa) was used as a model protein as it contains a single 
cysteine residue (Cys248) and no disulfide bridges, so that the role of TCEP is not complicated 
by any competing disulfide reductions. The yeast enolase was first denatured (8M urea) to 
expose the buried cysteine residue and then incubated with varying amounts of reducing 
agent (TCEP or THPP) prior to treatment with an equimolar amount of 2 kDa PEG-maleimide. 
The degree of conjugation was then evaluated by resolving the proteins using SDS-PAGE and 
visualising the change in mass by staining with Coomassie blue solution (Figure 2).  
 
 
Figure 2. SDS-PAGE analysis showing degree of PEGylation of yeast enolase protein in the presence of varying 
ratios of phosphine reducing agent to 2kDa PEG-maleimide (stained using Coomassie blue solution).  All 
conjugation experiments were performed in Tris.HCl buffer (pH 7.2) at 37°C for 18 hours using a 1:1 ratio of 
enolase to maleimide reagent. Lane 1: Marker protein (56kDa); Lane 2: enolase protein (control); Lanes 3-5: 
enolase treated with TCEP and maleimide-2kDa PEG in ratios of 1:10, 1:1 and 5:1; Lanes 6-8: enolase treated 
with THPP and maleimide-2kDa PEG in ratios of 1:10, 1:1 and 5:1.  
 
 It was observed that performing the PEGylation of denatured yeast enolase in the 
presence of excess maleimide resulted in good levels of protein PEGylation (Figure 2, lanes 3 
and 6). However, repeating the reaction in the presence of even just equimolar amounts of 
TCEP (Figure 2, lane 4) or THPP (Figure 2, lane 7), resulted in significant amounts of non-
PEGylated yeast enolase remaining. These results indicate that both TCEP and THPP react with 
maleimide at approximately the same rate as the addition of maleimide to the cysteinyl thiol. 
When the ratios of reducing agent to maleimide were increased to 5:1 (Figure 2, lane 5 for 
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TCEP and lane 8 for THPP), PEGylation of enolase was almost entirely abolished. These results 
suggest that even residual amounts of phosphine reducing agent present in protein 
PEGylation reactions are likely to result in measurable loss of conjugation yield and, as such, 
these reagents need to be removed prior to the introduction of maleimide. 
 
Incorporation of phosphine adducts into conjugation components containing 
multiple maleimides. It has been demonstrated here that TCEP reacts rapidly with maleimide 
to form ylenes which are remarkably stable towards nucleophilic attack over an appreciable 
pH range. For all of the conjugation reagents investigated thus far, which contain a single 
maleimide group, this reaction will result in consumption of alkylating agent and may reduce 
yields of conjugation. However, it was of also of interest to consider the reaction of TCEP with 
conjugation components containing multiple maleimide groups, such as those employed in 
the production of conjugate vaccines.34,35 For components containing multiple maleimides, 
potential may exist for its hetero-functionalisation by both the intended thiol nucleophile as 
well as any residual TCEP present during the conjugation reaction. Here, the antigenic 
polysaccharide Pn6B from the outer protective capsule of Streptococcus pneumoniae was 
chosen as model substrate to investigate the reaction of TCEP with conjugation components 
containing multiple maleimides. Pn6B (from ATCC) is a 0.9-1.5 MDa polysaccharide with a 
repeat unit of (→2-α-D-Galactopyranose-(1→3)-α-D-Glucopyranose-(1→3)-α-L-
rhamnopyranose-(1→4)-D-ribitol-5-phosphate→) (Figure 3a). Maleimide was introduced into 
a sample of Pn6B by treatment with N-(5-isocyanatopentyl)maleimide to give 15 (Figure 3b) 
where the degree of maleimide functionalisation was determined to be 4%, based on 1H NMR 
analysis. Analysis of the 31P NMR spectrum of Pn6B-maleimide 15 revealed a single peak at δ 
= -0.08 ppm, characteristic of the repeat unit phosphodiester backbone (Figure 3c).  
 
12 
 
 
Figure 3. Incorporation of ylene adducts into maleimide labelled antigen Pn6B. a) Chemical structure of repeat 
unit for capsular polysaccharide Pn6B. b) Reaction of maleimide labelled Pn6B (15) with TCEP to give the ylene 
16. c) 31P NMR spectrum of 15. d) 31P NMR spectrum of 16. 
 
 Compound (15) was treated with an aqueous solution of TCEP for 1 hour at room 
temperature, then purified extensively by gel filtration chromatography and subsequently 
lyophilised. 31P NMR analysis of the product showed two phosphorus signals, one 
corresponding to the repeat unit phosphodiester at δ = -0.08 ppm and the other characteristic 
of a maleimide-TCEP ylene (16) at δ = 34 ppm (Figure 3d). This result demonstrates that 
conjugation components activated with multiple maleimides, such as capsular 
polysaccharides used in conjugate vaccine production, are susceptible to ylene incorporation 
through reaction with TCEP.  
 
Conclusions    
Trialkylphosphines such as TCEP and THPP are popular as effective disulfide reducing 
agents in bioconjugation procedures. However, we have demonstrated here that both of 
these reducing agents are reactive towards commonly used Michael acceptors such as 
maleimide and vinyl sulfone. TCEP and THPP have been shown to react with maleimide to 
produce different products. TCEP reacts with maleimide to produce a stable ylene adduct that 
is resistant to nucleophilic attack by thiols. THPP reduces maleimide to succinimide which 
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could significantly reduce yields during the bioconjugation process. TCEP reacts with phenyl 
vinyl sulfone to generate a penta co-ordinate phosphorus product, while THPP reacts with the 
same sulfone to produce a complex mixture of products. These reactions will likely lower 
yields of bioconjugate production and may also complicate purification protocols. It is clearly 
evident that both the reducing agents need to be completely removed from bioconjugations 
before introducing the alkylating reagent to the reaction. 
 
Experimental Procedures 
 
Reaction of TCEP with N-ethyl maleimide:  
Synthesis of N-ethyl-3-(tris(carboxyethyl)phosphorylidene)pyrrolidine-2,5-dione (4) 
N-ethyl maleimide 3 (10.0 mg, 0.08 mmol) and TCEP 1 (0.9 eq., 20.6 mg, 0.072 mmol) 
were dissolved in a mixture of THF (1 mL) and argon purged aqueous sodium phosphate (0.1 
M, pH = 7.0, 9 mL) and stirred under argon at room temperature for 1 hour. The solution was 
then concentrated in vacuo to 3 mL then loaded onto a C-18 column for purification (100 % 
H2O → 20 % MeCN/H2O) to yield 4 as a white sticky solid (19.7 mg, 73 %).  1H-NMR (D2O) 400 
MHz:  δ = 1.05 (t, 3H, CH3, J = 7.2 Hz), 2.73-2.84 (m, 12H, 3 x CH2CH2CO), 3.09-3.26 (m, 2H, 
CCH2CO), 3.49 (q, 2H, NCH2, J = 7.2 Hz).  13C NMR, D2O, 125 MHz:  δ 11.54 (CH3), 14.34 (d, 3C, 
PCH2, J = 49.9 Hz), 25.82 (d, 3C, 3 x CH2CH2CO2H, J = 3.5 Hz), 29.39 (CCH2CO), 33.51 (m, 
CH2CCO), 35.05 (NCH2), 172.95 (CCO, J = 3.0 Hz), 174.16 (d, 3C, 3 x CH2CO2H, J = 11.9 Hz), 
175.97 (d, CH2CON, J = 8.8 Hz).  31P NMR, D2O, 162 MHz:  δ 39.2.  HRMS: Expected for 
C15H21N1O8P1 (M-H+) = m/z 374.1005. Found: m/z 374.1029.  Infrared (KBr): 3442, 1700 cm-1.  
HPLC (retention time: 12.81 mins., purity: 93 %), column:  Phenomenex Luna-C18 (250 x 4.60 
mm), gradient:  (0.7 mL/min), 100 % water containing 0.1 % TFA → 100 % MeCN over 16 
minutes, detection at 225 nm. 
 
Reaction of THPP with N-ethyl maleimide:  
Synthesis of N-ethyl succinimide (7) 
A solution of THPP 2 (0.9 eq., 29.9 mg, 0.144 mmol) was prepared in THF (1 mL) and 
argon purged aqueous sodium phosphate (0.1 M, pH = 7.0, 9 ml). N-ethyl maleimide 3 (20.0 
mg, 0.160 mmol) was added slowly to the rapidly stirring solution of THPP. The reaction was 
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left to stir for 30 minutes at room temperature. A further 0.1 eq. of THPP was added and left 
to stir for an additional 30 minutes. The reaction was diluted with 25 mL of diethyl ether and 
extracted with water (30 mL). The aqueous layer was extracted with diethyl ether (2 x 30 mL). 
The organic extraction layers were combined and dried using MgSO4. The mixture was filtered 
and the organic solution was concentrated (550 mm Hg, 25 °C). The crude was purified by 
silica gel chromatography (CH2Cl2  2 % acetone/CH2Cl2) to yield 7 as a clear oil (12.4 mg, 61 
%). Spectral data consistent with literature.36 1H NMR (CDCl3) 400 MHz:   = 1.07 (t, 3H, 
CH2CH3, J = 7.2 Hz), 2.61 (s, 4H, 2 x COCH), 3.46 (q, 2H, NCH2CH3, J = 7.2 Hz).  13C-NMR (CDCl3) 
100 MHz:  = 12.8 (CH2CH3), 28.0 (2 x COCH), 33.5 (NCH2CH3), 177.0 (2 x NCOCH).  HRMS:  
Expected for C6H9N1Na1O2 (M+Na+) = m/z 150.0525. Found: m/z 150.0531. 
 
Reaction of TCEP with the phenyl vinyl sulfone:  
Synthesis of 3,3'-{5-oxo-2-[2-(phenylsulfonyl)ethyl]-1,2 5-oxaphospholane-2,2-
diyl}dipropanoic acid (13) 
Phenyl vinyl sulfone 12 (10.0 mg, 0.059 mmol) and TCEP 1 (0.9 eq., 15.3 mg, 0.054 
mmol) was dissolved in THF (2 mL) and argon purged aqueous sodium phosphate (0.1 M, pH 
= 7.0, 8 ml) and stirred under argon at room temperature for 1 hour. The reaction was 
concentrated in vacuo to 3 mL and then loaded onto a C-18 column for purification (100 % 
H2O  40 % MeCN/H2O) to yield 13 as a white solid (18.8 mg, 84 %).   1H-NMR (D2O) 400 MHz: 
 = 2.54-2.63 (m, 12H, 3 x CH2CH2CO), 2.66-2.74 (m, 2H, SCH2CH2), 3.72 (m, 2H, SCH2CH2), 
7.67-7.95 (m, 5H, Ar-H).  13C-NMR (D2O) 100 MHz:    13.5 (d, PCH2CH2, J = 49.3 Hz), 14.6 (d, 3 
x CH2CH2CO2, J = 50.1 Hz), 26.5 (d, 3 x CH2CH2CO2, J = 3.8 Hz), 47.2 (SCH2CH2), 128.09 & 130.0 
(4C, ortho & meta Ar-C), 135.45 (ipso -C & para Ar-C), 175.3 (d, 3 x CH2 CO2H, J = 12.7 Hz).  31P-
NMR (D2O) 162 MHz:   = 37.7.  HRMS:  Expected for C17H22O8P1S1 (M-H+) = m/z 417.0778.  
Found: m/z 417.0797.  Melting point: 115 C.  Infrared (KBr):  3427, 2925, 1721, 1600, 1419, 
1153 cm-1.  HPLC (retention time:  12.43 mins, purity:  97 %), column:  Phenomenex Luna-C18 
(250 x 4.60 mm), gradient:  (0.7 mL/min) 10 % MeCN in water (containing 0.1 % TFA)  100 
% MeCN over 20 minutes, detection at 280 nm. 
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